Search

everythinglearnresearchcommunity

for

Search:↓

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

Certain immune cells may cause hair loss by reacting to stressed hair follicles.

T cells with memory features grow in number and gather around hair follicles when there are not enough immune cells.

Somatostatin helps hair follicles suppress immune responses, which might aid in treating certain hair loss conditions.

In alopecia areata, certain immune cells increase and express a protein linked to immune activation.

The document provides 70 multiple choice questions to improve haematology skills.

Men, diabetes, and high inflammation levels lead to higher COVID-19 antibodies.

Lambs' skin showed similar but more severe responses to a second orf virus infection, involving immune cells and new skin formation.

Alopecia areata severity is linked to increased TH1 and TH2 activity.

Alopecia areata may be caused by antibodies targeting specific hair follicle proteins, hindering hair growth.

Trichohyalin may trigger the immune response causing alopecia areata.

T cells and bacteria in the gut and skin help maintain health and protect against disease.

Hair growth phase in mice weakens certain immune responses.

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

Thyroid-related genes are active in skin cells and may affect autoimmune conditions.

A specific immune response helps control mite populations on the skin, maintaining healthy hair follicles.

Higher monocyte counts predict less effective adalimumab treatment in hidradenitis suppurativa patients.

Nonimmunogenic forms of keratins K71 and K31 can delay and prevent alopecia areata.

Stem cell activity influences autoimmune disease outcomes by affecting immune responses and tissue regeneration.

γδ T cells adapt uniquely to different tissues in mice.

IFN-γ production by CD4 T cells is crucial for causing alopecia areata.

Fetal skin has unique immune cells different from adult skin.

Monoclonal antibodies LT-1, LT-2, and LT-7 help diagnose certain blood cancers.

Patients with alopecia areata have higher levels of certain immune markers, suggesting new treatment targets.

Melanogenesis-related proteins may trigger immune responses in alopecia areata patients.

Human hair follicles have their own thyroid hormone system.

Acne patients' skin, both with and without lesions, shows a strong immune response and higher antimicrobial activity.

A new patch can deliver stable antibodies over time for potential HIV treatment.

Type-2 immunity may influence skin diseases and could be targeted for treatment.